Get notified when LH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- New Civil Investigative Demand (new) — On August 20, 2026, the Company was served with a civil investigative demand issued by the North Carolina Attorney General’s Office requiring the production of documents related to urine drug testing. The Company is cooperating with the information requests.
Labcorp's third-quarter revenue rose 6.9% to $3.81B, while net earnings attributable to Labcorp Holdings Inc. increased 0.7% to $262.8M.
Filed October 30, 2026 · Period ending September 30, 2026 · Compared to 10-Q Oct 31, 2025 · ~2 min read
Key Changes
-
high
Revenue increased 6.9% to $3.81B in the third quarter, which the company attributes to organic revenue of 5.5% and acquisitions, net of divestitures, of 1.5%, partially offset by unfavorable foreign currency translation of 0.1%.
-
high
Net earnings attributable to Labcorp Holdings Inc. rose 0.7% to $262.8M, while diluted EPS increased 3.2% to $3.22.
-
high
The company disclosed a new civil investigative demand from the North Carolina Attorney General's Office related to urine drug testing, adding regulatory scrutiny.
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FUL 10-Q) is open in full — no account needed.
Partner
Trade LH commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Nov 2, 2026 · How we verify